| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |